Balancing Accelerated Approval for Drugs With Accelerated Withdrawal--Reply

JAMA Intern Med. 2016 Apr;176(4):567. doi: 10.1001/jamainternmed.2016.0374.

Authors

Chul Kim¹, Vinay Prasad²

Affiliations

¹ Medical Oncology Service, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
² Division of Hematology Oncology/Knight Cancer Institute, Oregon Health & Science University, Portland3Department of Public Health and Preventive Medicine, Oregon Health & Science University, Portland4Senior Scholar in the Center for Health Care Ethics, Or.

PMID: 27043117
DOI: 10.1001/jamainternmed.2016.0374

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents / therapeutic use*
Drug Approval / methods*
Humans

Substances

Antineoplastic Agents